We are live on
!
Find out more
Connor, Clark & Lunn Investment Management (CC&L) Portfolio holdings
AUM
$43.4B
1-Year Est. Return
51.29%
This Fund
S&P 500
This Quarter
Est. Return
+4.23%
1 Year Est. Return
+51.29%
3 Year Est. Return
+133.48%
5 Year Est. Return
+173.9%
10 Year Est. Return
+551.09%
AUM
$22.1B
AUM Growth
+$1.49B
(+7.2%)
Cap. Flow
+$1.52B
Cap. Flow
% of AUM
6.88%
Top 10 Holdings %
Top 10 Hldgs %
26.41%
Holding
1,688
New
288
Increased
663
Reduced
425
Closed
302
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco MSCI USA ETF
PBUS
|
+$260M |
| 2 |
Shopify
SHOP
|
+$160M |
| 3 |
Royal Bank of Canada
RY
|
+$114M |
| 4 |
Brookfield Asset Management
BAM
|
+$110M |
| 5 |
Canadian Natural Resources
CNQ
|
+$109M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
B
Barrick Mining
B
|
+$145M |
| 2 |
Restaurant Brands International
QSR
|
+$108M |
| 3 |
Cenovus Energy
CVE
|
+$79.9M |
| 4 |
Rogers Communications
RCI
|
+$75.8M |
| 5 |
iShares MSCI India ETF
INDA
|
+$71.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 25.77% |
| 2 | Technology | 20.79% |
| 3 | Energy | 11.79% |
| 4 | Industrials | 11.45% |
| 5 | Materials | 7.79% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1351
Enanta Pharmaceuticals
ENTA
$402M
| $142K | ﹤0.01% |
24,636
+12,868
| +109% | +$123K |
|
|
NVRO
1352
DELISTED
NEVRO CORP.
NVRO
| $140K | ﹤0.01% |
+37,702
| New | +$174K |
|
1353
SmartRent
SMRT
$276M
| $131K | ﹤0.01% |
74,619
-10,934
| -13% | -$18.3K |
|
1354
Ecopetrol
EC
$35.3B
| $123K | ﹤0.01% |
+15,504
| New | +$125K |
|
1355
Mercer International
MERC
$33.9M
| $120K | ﹤0.01% |
18,400
-9,423
| -34% | -$61.7K |
|
1356
Telos
TLS
$333M
| $114K | ﹤0.01% |
33,362
-121,483
| -78% | -$434K |
|
1357
DHI Group
DHX
$169M
| $112K | ﹤0.01% |
63,007
+1,348
| +2% | +$2.38K |
|
|
BZUN
1358
Baozun
BZUN
$167M
| $106K | ﹤0.01% |
38,862
-451,909
| -92% | -$1.37M |
|
1359
Regenxbio
RGNX
$700M
| $104K | ﹤0.01% |
13,515
-47,773
| -78% | -$449K |
|
1360
FIGS
FIGS
$2.43B
| $104K | ﹤0.01% |
+16,816
| New | +$98K |
|
1361
OraSure Technologies
OSUR
$278M
| $95.4K | ﹤0.01% |
26,419
-2,312
| -8% | -$9.2K |
|
1362
Crawford & Co Class B
CRD.B
$576M
| $93.8K | ﹤0.01% |
8,067
-2,656
| -25% | -$30K |
|
1363
Lineage Cell Therapeutics
LCTX
$271M
| $93.4K | ﹤0.01% |
185,908
-5,528
| -3% | -$4.06K |
|
|
SBDS
1364
DELISTED
Solo Brands Inc
SBDS
| $91.2K | ﹤0.01% |
2,000
+181
| +10% | +$8.97K |
|
|
ADVM
1365
DELISTED
Adverum Biotechnologies
ADVM
| $85.3K | ﹤0.01% |
18,261
+5,057
| +38% | +$34K |
|
1366
Gaia
GAIA
$32.8M
| $75.9K | ﹤0.01% |
16,896
+6,814
| +68% | +$37.3K |
|
1367
Ultrapar
UGP
$6.47B
| $75.6K | ﹤0.01% |
+28,730
| New | +$95.2K |
|
|
GBIO
1368
DELISTED
Generation Bio
GBIO
| $67.4K | ﹤0.01% |
6,356
-1,016
| -14% | -$18.1K |
|
1369
Liberty Latin America Class A
LILA
$1.67B
| $66.1K | ﹤0.01% |
+15,298
| New | +$83.8K |
|
1370
UNIFI
UFI
$124M
| $65.4K | ﹤0.01% |
+10,471
| New | +$64.1K |
|
|
CRON
1371
Cronos Group
CRON
$1.17B
| $62.4K | ﹤0.01% |
+31,100
| New | +$64.9K |
|
1372
Biomea Fusion
BMEA
$92.8M
| $55.7K | ﹤0.01% |
+14,362
| New | +$114K |
|
1373
Adicet Bio
ACET
$78.4M
| $49.2K | ﹤0.01% |
3,198
-8,102
| -72% | -$153K |
|
1374
Eledon Pharmaceuticals
ELDN
$289M
| $46.6K | ﹤0.01% |
+11,303
| New | +$44.6K |
|
|
PFIE
1375
DELISTED
Profire Energy, Inc
PFIE
| $44.9K | ﹤0.01% |
17,668
+2,216
| +14% | +$5.01K |
|
Similar funds
LP
HF
TI
Connor, Clark & Lunn Investment Management (CC&L)'s Q4 2024 Portfolio in Review
As of Q4 2024, Connor, Clark & Lunn Investment Management (CC&L) held 1,688 positions worth $22.1B, up 7.2% from $20.6B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
Connor, Clark & Lunn Investment Management (CC&L) deployed $1.52B of net new capital in Q4 2024, opening 288 new positions and adding to 663 existing holdings. Its largest new stake was Invesco MSCI USA ETF: 4,393,117 shares worth $259M.
By sector, the portfolio is most concentrated in Financials at 26% of assets, up from 25% a quarter earlier, followed by Technology and Energy.
On the sell side, the largest reduction was Barrick Mining, an estimated $145M trimmed.
- Connor, Clark & Lunn Investment Management (CC&L)'s largest Q4 2024 buy was Invesco MSCI USA ETF: 4,393,117 shares worth $259M.
- Connor, Clark & Lunn Investment Management (CC&L) added most to Shopify in Q4 2024, an estimated $160M increase.
- Connor, Clark & Lunn Investment Management (CC&L)'s biggest Q4 2024 reduction was Barrick Mining, cutting an estimated $145M.
- Connor, Clark & Lunn Investment Management (CC&L) fully exited TJX Companies in Q4 2024, selling an estimated $36.9M.
- Connor, Clark & Lunn Investment Management (CC&L)'s ten largest holdings make up 26% of its $22.1B portfolio in Q4 2024.
- Connor, Clark & Lunn Investment Management (CC&L) opened 288 new positions and closed 302 in Q4 2024.
- Connor, Clark & Lunn Investment Management (CC&L)'s portfolio value rose 7.2% quarter-over-quarter to $22.1B.
Based on Connor, Clark & Lunn Investment Management (CC&L)'s 13F filing for Q4 2024, filed 10 Feb 2025.